Article
Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs.
Clinical lung cancer - 1 Jul 2017
Lynch Julie A, Berse Brygida, Chun Danielle, Rivera Donna, Filipski Kelly K, Kulich Scott, Viernes Benjamin, DuVall Scott L, Kelley Michael J
Abstract excerpt
INTRODUCTION: We examined mutational testing of the epidermal growth factor gene (EGFR) and erlotinib treatment among veterans diagnosed with non-small-cell lung cancer in the United States Department of Veterans Affairs (VA). Our objectives were to identify the prevalence of clinically actionable EGFR mutations, to determine whether testing and treatment were guideline concordant, to evaluate the impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.